Lineage Cell Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Lineage Cell Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $14M.
  • Lineage Cell Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.42M, a 294% increase from 2022.
  • Lineage Cell Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.63M, a 95.6% decline from 2021.
  • Lineage Cell Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $36.9M, a 23.7% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.42M +$4.79M +294% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $1.63M -$35.3M -95.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $36.9M +$7.07M +23.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $29.9M +$29.2M +4740% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $617K -$5.16M -89.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $5.77M -$49.6M -89.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $55.4M +$22.6M +69% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $32.8M -$32M -49.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $64.8M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2013 $34.3M +$32.4M +1691% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-17
2012 $1.91M -$1.95M -50.5% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-17
2011 $3.86M -$21.9M -85% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $25.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.